253 related articles for article (PubMed ID: 21726674)
1. Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.
Sultana R; Robinson RA; Di Domenico F; Abdul HM; St Clair DK; Markesbery WR; Cai J; Pierce WM; Butterfield DA
J Proteomics; 2011 Oct; 74(11):2430-40. PubMed ID: 21726674
[TBL] [Abstract][Full Text] [Related]
2. Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.
Bader Lange ML; St Clair D; Markesbery WR; Studzinski CM; Murphy MP; Butterfield DA
Neurobiol Dis; 2010 Apr; 38(1):104-15. PubMed ID: 20083199
[TBL] [Abstract][Full Text] [Related]
3. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
Flood DG; Reaume AG; Dorfman KS; Lin YG; Lang DM; Trusko SP; Savage MJ; Annaert WG; De Strooper B; Siman R; Scott RW
Neurobiol Aging; 2002; 23(3):335-48. PubMed ID: 11959395
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic characteristics of I213T mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein C-terminal fragment beta.
Shimojo M; Sahara N; Mizoroki T; Funamoto S; Morishima-Kawashima M; Kudo T; Takeda M; Ihara Y; Ichinose H; Takashima A
J Biol Chem; 2008 Jun; 283(24):16488-96. PubMed ID: 18430735
[TBL] [Abstract][Full Text] [Related]
5. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.
Sompol P; Ittarat W; Tangpong J; Chen Y; Doubinskaia I; Batinic-Haberle I; Abdul HM; Butterfield DA; St Clair DK
Neuroscience; 2008 Apr; 153(1):120-30. PubMed ID: 18353561
[TBL] [Abstract][Full Text] [Related]
6. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
7. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
Siman R; Reaume AG; Savage MJ; Trusko S; Lin YG; Scott RW; Flood DG
J Neurosci; 2000 Dec; 20(23):8717-26. PubMed ID: 11102478
[TBL] [Abstract][Full Text] [Related]
8. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
Steiner H; Capell A; Leimer U; Haass C
Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
[TBL] [Abstract][Full Text] [Related]
9. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer's Disease.
Kim M; Bezprozvanny I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768421
[TBL] [Abstract][Full Text] [Related]
11. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
12. A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity.
Heilig EA; Xia W; Shen J; Kelleher RJ
J Biol Chem; 2010 Jul; 285(29):22350-9. PubMed ID: 20460383
[TBL] [Abstract][Full Text] [Related]
13. Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
Huang Q; Aluise CD; Joshi G; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
J Neurosci Res; 2010 Sep; 88(12):2618-29. PubMed ID: 20648652
[TBL] [Abstract][Full Text] [Related]
14. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
[TBL] [Abstract][Full Text] [Related]
15. Distribution and expression of Pen-2 in the central nervous system of APP/PS1 double transgenic mice.
Chu Y; Peng X; Long Z; Wang K; Luo S; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):258-66. PubMed ID: 25736404
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
[TBL] [Abstract][Full Text] [Related]
17. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.
Robinson RA; Joshi G; Huang Q; Sultana R; Baker AS; Cai J; Pierce W; St Clair DK; Markesbery WR; Butterfield DA
Proteomics; 2011 Nov; 11(21):4243-56. PubMed ID: 21954051
[TBL] [Abstract][Full Text] [Related]
19. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
Agca C; Klakotskaia D; Schachtman TR; Chan AW; Lah JJ; Agca Y
BMC Neurosci; 2016 Jul; 17(1):46. PubMed ID: 27388605
[TBL] [Abstract][Full Text] [Related]
20. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
